Related Experiment Videos
Anesthesia in pregnancy with heart disease
Ankur Luthra1, Ritika Bajaj2, Anudeep Jafra1
1Department of Anaesthesia and Intensive Care, Nehru Hospital, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saudi Journal of Anaesthesia
|October 17, 2017
Summary
Managing pregnant women with heart disease is complex. Anesthesia and analgesia are crucial for reducing maternal and neonatal mortality in these high-risk pregnancies.
Area of Science:
- Cardiology
- Anesthesiology
- Obstetrics
Background:
- Cardiac diseases increasingly coexist with pregnancy due to medical advancements.
- In developing nations, rheumatic heart disease complicates nearly 6% of pregnancies.
- Maternal deaths often occur during or after childbirth, highlighting anesthesiologist importance.
Purpose of the Study:
- To emphasize the critical role of anesthesiologists in managing pregnant women with heart disease.
- To highlight the impact of anesthesia and analgesia on maternal and neonatal outcomes.
Main Methods:
- Review of current challenges in managing cardiac disease during pregnancy.
- Analysis of the influence of anesthetic agents on maternal and fetal prognosis.
Main Results:
- Cardiac innovations and transplants increase the frequency of coexisting heart disease and pregnancy.
- Anesthetic management significantly impacts maternal and neonatal mortality and morbidity.
- Properly administered anesthesia can improve outcomes for mother and child.
Conclusions:
- Effective anesthesia and analgesia are vital for reducing mortality and morbidity in pregnant patients with heart disease.
- Anesthesiologists play a key role in improving the prognosis for mothers and newborns affected by cardiac conditions.